Capital World Investors Zai Lab LTD Transaction History
Capital World Investors
- $633 Billion
- Q4 2024
A detailed history of Capital World Investors transactions in Zai Lab LTD stock. As of the latest transaction made, Capital World Investors holds 6,433,424 shares of ZLAB stock, worth $221 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,433,424
Previous 6,435,383
0.03%
Holding current value
$221 Million
Previous $155 Million
8.46%
% of portfolio
0.03%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding ZLAB
# of Institutions
146Shares Held
53MCall Options Held
103KPut Options Held
439K-
Wellington Management Group LLP Boston, MA6.66MShares$229 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X06.57MShares$226 Million0.09% of portfolio
-
Morgan Stanley New York, NY3.17MShares$109 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$86.3 Million1.07% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.35MShares$80.9 Million0.01% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.37B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...